Back

Identifying Distinct Molecular Response of CAR-T cells to Solid Tumors by Synthetic Single-Cell Transcriptomic Analyses

Luo, Y. H.; Forte, E.; Tanaka, Y.

2025-09-18 cancer biology
10.1101/2025.09.17.676755 bioRxiv
Show abstract

Chimeric Antigen Receptor (CAR)-T cell therapy is a novel personalized treatment that engineers patient immune cells to fight against cancer cells. Recently, CAR-T cell therapy has demonstrated remarkable success in the treatment of hematopoietic cancers, whereas the treatment of solid tumors is more challenging, likely in part due to their severely immunosuppressive tumor microenvironment. To address distinct molecular responses of CAR-T cells between blood and solid tumors, we performed synthetic analysis of single-cell transcriptomics of CAR-T cells and identified unique immunosuppressive subpopulations and aberrant signalling inductions in CD4+ and CD8+ CAR-T cells in the context of solid tumors. Furthermore, we also found that PD-1-independent exhaustion-like CD8+ CAR-T cells, characterized by high expression of TNFRSF9 and CCL3, were preferentially generated under solid tumor stimulation. Collectively, our comprehensive analyses provide essential molecular insights into solid tumor-stimulated CAR-T cells and assists in overcoming the limited efficacy of CAR-T cell therapy against solid tumors.

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.